TCON: TRACON Pharmaceuticals, Inc. Stock

by  •  • Comments Off on TCON: TRACON Pharmaceuticals, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 3.83
Enterprise Value ($M) -4.06
Book Value ($M) -1.76
Book Value / Share -0.66
Price / Book -2.17
NCAV ($M) -2.71
NCAV / Share -1.01
Price / NCAV -1.41

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) 0.14
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.80
Current Ratio 0.80

Balance Sheet (mrq) ($M)
Current Assets 8.40
Assets 9.36
Liabilities 11.12
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 12.04
Operating Income -6.90
Net Income -3.59
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 3.68
Cash from Investing 0.00
Cash from Financing -12.54

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-05 13G/A Ikarian Capital, LLC 5.90 -3.42
03-19 13G/A aaronson wayne 2.30 -59.69
02-14 13G/A Lincoln Park Capital Fund, LLC 0.38 -95.07
02-09 13D/A Opaleye Management Inc. 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-03-05 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)

Similar Companies
SXTC – China SXT Pharmaceuticals, Inc. SXTP – 60 Degrees Pharmaceuticals, Inc.
SYBX – Synlogic, Inc. TCRT – Alaunos Therapeutics, Inc.
TELO – Telomir Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io